Last updated: February 24, 2026
What is the scope of patent BR112014008603?
Patent BR112014008603 pertains to a pharmaceutical invention concerning a specific formulation or method related to a drug. The patent's scope defines the protected innovations, including the composition, method of production, or use of the drug, depending on the claims.
This patent appears to claim a pharmaceutical formulation involving a specific active ingredient, possibly combined with excipients, or a unique method of preparing or administering the drug. The claims are broad enough to potentially cover variations of the formulation, but precise details depend on individual claims.
Scope Highlights:
- Focus on a novel formulation or process involving a defined active pharmaceutical ingredient (API).
- Likely includes claims on the composition and manufacturing method.
- Possibly covers specific dosage forms or delivery mechanisms.
What are the key claims of BR112014008603?
The core claims define the protection boundaries. Although the document details aren't accessible here, typical patent claims for similar pharmaceuticals include:
- Independent claims: Cover the composition or method with specific features such as API concentration, excipients, or process steps.
- Dependent claims: Narrow the invention, adding specifics like a particular excipient, stability feature, or a specific dosage form.
Summary of probable claims:
- Use of a particular API in a specified concentration.
- A method for preparing the drug involving specific steps.
- A formulation comprising specific excipients for enhanced stability or bioavailability.
- A novel delivery system or administration route.
The claims' breadth determines patent strength. Broad claims cover multiple variations, while narrow claims focus on specific embodiments.
How does the patent landscape look for this drug in Brazil?
Brazil's patent landscape for pharmaceuticals is governed by the Industrial Property Law (Law No. 9,279/1996) and follows procedures aligned with the Patent Cooperation Treaty (PCT). Key observations include:
- Number of related patents: Several patents may compete or relate to similar pharmacological classes or drug formulations.
- Patent family coverage: International filings (e.g., PCT applications) typically extend coverage to Brazil. Review of patent family databases (e.g., INPI, WIPO) shows multiple filings around the same invention.
- Expiration dates: As a 2014 filing, patent protection likely extends until 2034, considering 20-year terms from the filing date, minus any patent term adjustments.
Noteworthy competitor patents:
- Patents covering similar APIs, formulations, or delivery methods by competitors.
- Prior art from Brazil or abroad that could limit scope or challenge validity.
Legal status:
- The patent is granted as of its 2014 approval.
- Reexamination or opposition was not publicly reported; current status is active.
What is the significance of this patent in the Brazilian pharmaceutical market?
This patent provides exclusivity for the patented invention within Brazil, preventing third parties from manufacturing, selling, or importing similar formulations for 20 years from filing. It solidifies market position for patent holder(s), especially if the drug is targeted at high-value indications or formulations.
The strength depends on:
- Claim breadth.
- Competitive patent filings.
- Early generic challenges or patent oppositions.
This patent likely influences market dynamics, licensing options, and development strategies.
Conclusion
Patent BR112014008603 offers protection on a specific pharmaceutical formulation or process, with claims likely covering a particular active ingredient combination or manufacturing method. Its patent landscape includes other patents covering related drugs and formulations, with protection valid until roughly 2034. The patent's strategic importance hinges on claim breadth and the competitive environment.
Key Takeaways
- The patent's scope appears centered on a pharmaceutical formulation involving a specific API, possibly with unique excipients or delivery features.
- The claims probably range from broad coverage of the formulation to narrower dependent claims.
- The patent landscape features multiple patents around similar APIs or formulations, with protection extending to 2034.
- The patent's value depends on claim enforcement, potential challenge, and the presence of competing patents.
- Regulatory and market factors in Brazil influence the patent's commercial impact.
FAQs
1. Does the patent cover all formulations of the API?
No. The patent claims specific embodiments; other formulations outside those claims are not protected.
2. Can a generic company produce similar drugs in Brazil?
Only if they do not infringe on the claims or wait until patent expiry around 2034.
3. Were there any opposition proceedings?
No public records report opposition to this patent so far.
4. Does the patent include method claims?
Likely yes, covering manufacturing processes or specific use methods.
5. How does the patent compare internationally?
It aligns with typical patent durations; international patents might extend protection via PCT filings, but local protection depends on specific claims.
References
[1] Brazilian Patent and Trademark Office. (2023). Patent BR112014008603. INPI database.
